Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cerilliant
Queensland Health
Baxter
Accenture
Covington
Dow
Mallinckrodt
Daiichi Sankyo

Generated: August 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SODIUM BENZOATE; SODIUM PHENYLACETATE

« Back to Dashboard

Clinical Trials for sodium benzoate; sodium phenylacetate

Trial ID Title Status Sponsor Phase Summary
NCT00004767 Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders Completed Johns Hopkins University Phase 2 OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.
NCT00004767 Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders Completed National Center for Research Resources (NCRR) Phase 2 OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.
NCT00597909 Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy Terminated Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 2 The primary purpose of this study is to evaluate the safety and effectiveness of Ammonul® in subjects who become hospitalized with Grade 3 or 4 hepatic encephalopathy (HE).
NCT00977600 A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P) Completed Ucyclyd Pharma, Inc. Phase 1 To determine the safety and tolerability of single oral doses of HPN-100 as a formulation (GT4P-F) and GT4P as the active pharmaceutical ingredient (GT4P-API) administered to healthy male subjects.
NCT00977600 A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P) Completed Horizon Pharma Ireland, Ltd., Dublin Ireland Phase 1 To determine the safety and tolerability of single oral doses of HPN-100 as a formulation (GT4P-F) and GT4P as the active pharmaceutical ingredient (GT4P-API) administered to healthy male subjects.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for sodium benzoate; sodium phenylacetate

Condition Name

Condition Name for sodium benzoate; sodium phenylacetate
Intervention Trials
Amino Acid Metabolism, Inborn Errors 1
Hepatic Encephalopathy 1
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for sodium benzoate; sodium phenylacetate
Intervention Trials
Amino Acid Metabolism, Inborn Errors 1
Hepatic Encephalopathy 1
Brain Diseases 1
Urea Cycle Disorders, Inborn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for sodium benzoate; sodium phenylacetate

Trials by Country

Trials by Country for sodium benzoate; sodium phenylacetate
Location Trials
United States 2
Ukraine 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for sodium benzoate; sodium phenylacetate
Location Trials
Texas 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for sodium benzoate; sodium phenylacetate

Clinical Trial Phase

Clinical Trial Phase for sodium benzoate; sodium phenylacetate
Clinical Trial Phase Trials
Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for sodium benzoate; sodium phenylacetate
Clinical Trial Phase Trials
Completed 2
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for sodium benzoate; sodium phenylacetate

Sponsor Name

Sponsor Name for sodium benzoate; sodium phenylacetate
Sponsor Trials
Horizon Pharma Ireland, Ltd., Dublin Ireland 2
Johns Hopkins University 1
Ucyclyd Pharma, Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for sodium benzoate; sodium phenylacetate
Sponsor Trials
Other 2
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Farmers Insurance
Julphar
Mallinckrodt
Medtronic
QuintilesIMS
Accenture
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.